Gastrointestinal Market Is Projected to Reach at a 35800 Million USD by the End of 2025, with a CAGR of 0.8%: QY Research
Gastrointestinal (GI) disorders include functional bowel diseases such as irritable bowel syndrome (IBS) and inflammatory bowel diseases such as Crohn's disease (CD) and colitis. Some gastrointestinal drug can control or moderate the symptoms of gastrointestinal disorders.
View full press release